Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials

Area of Science:

• Medicine
• Virology
• Public Health

Background:

• Coronavirus disease 2019 (COVID-19) is a severe acute respiratory viral infection caused by SARS-CoV-2.
• The rapid global spread has led to a pandemic, creating a public health emergency with increasing cases worldwide.
• Disease management is complicated by treatment challenges and limited personal protective equipment.

Purpose of the Study:

• To review current management strategies for COVID-19.
• To highlight the use of existing drugs and emerging therapies.
• To emphasize the need for definitive treatments and preventive measures.

Main Methods:

• Review of current clinical practices and therapeutic options for COVID-19.
• Analysis of off-label drug use (e.g., hydroxychloroquine) and emergency use authorizations (e.g., remdesivir).
• Evaluation of convalescent serum as an interim treatment option.

Main Results:

• Off-label drug use and emergency authorizations offer potential benefits for critically ill patients.
• Convalescent serum has demonstrated some interim therapeutic value.
• The search for definitive treatments and preventive strategies, including vaccines, is ongoing.

Conclusions:

• COVID-19 management requires a multi-faceted approach, utilizing available therapies while awaiting more effective interventions.
• Continued research into vaccines and treatments is crucial for controlling the pandemic.
• Addressing challenges in treatment options and resource availability is vital for healthcare providers.